GlassScriptPhysician profile
Sonali Shukla
NPI 1003862228
$1,384.69
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Anatomic Pathology provider received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.76 · 2021: $247 · 2022: $267 · 2023: $470 · 2024: $262 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $336.45 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $266.50 | 2022-2024 | Watchman Access System |
| Ethicon INC. | $130.76 | 2023 | Monarch Platform |
| Lilly USA, LLC | $125.00 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $125.00 | 2023 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $122.80 | 2024 | Inpefa |
| Ortho-Clinical Diagnostics, INC. | $28.18 | 2020-2024 | Ortho |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonali Shukla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.